Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia

Condition:   Leukoplakia, Oral
Intervention:   Drug: Nivolumab
Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb
Not yet recruiting

https://ift.tt/2Iw4WIQ